Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Steroid-sparing Effects of Etanercept in a Patient with Steroid-dependent Adult-onset Still's Disease
Yasuhiro KiyonagaKeisuke MaeshimaChiharu ImadaMiwa HaranakaKoji IshiiHirotaka Shibata
Author information
JOURNAL OPEN ACCESS

2014 Volume 53 Issue 11 Pages 1209-1213

Details
Abstract

We herein report the case of an 84-year-old man with steroid-dependent adult-onset Still's disease (AOSD) whose daily steroid dose was successfully tapered after etanercept treatment. The corticosteroids worked well initially, and the patient went into remission promptly; however, he suffered a relapse due to steroid tapering. Because treatment with cyclosporine and methotrexate was ineffective, reducing the steroid dose was difficult, and the corticosteroids induced myopathy and diabetes. However, steroid tapering was accomplished in combination with etanercept therapy, and the patient's steroid-induced side effects disappeared. Etanercept should therefore be considered as a steroid-sparing treatment option in patients with steroid-responsive, steroid-dependent AOSD.

Content from these authors
© 2014 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top